Research article · 27 Jul 2026
Conference abstractPublished 17 Dec 2014
The dual opposite effects of cilostazol on fertility: An animal model
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The current contraceptive pills are associated with cardiovascular and cancer diseases because of their steroidal nature. While scientific research has developed many antibiotics and antihypertensive drugs using different pharmacological approaches, the pharmacological development of contraceptive medications that is not steroidal in nature has yet to be achieved. Cilostazol (CLZ) is a phosphodiesterase IIIA inhibitor that is prescribed for patients with intermittent claudication (Pletal®). Using the mouse animal model, we found that CLZ is capable of inhibiting oocyte maturation in vitro, in vivo, and to block pregnancy in naturally cycling mice (P<0.0001). CLZ results in ovulation of immature oocytes that cannot be fertilized. This contraceptive approach is different from that of steroidal contraceptives, which impairs follicular development and blocks ovulation. We then allowed for ovulated immature oocytes to mature in vitro or in the oviducts. We found these oocytes are of advanced cytoplasmic and nuclear maturation and higher fertilization rates when compared with ovulated mature oocytes from animals that were not treated with CLZ (P<0.001). CLZ also improved the survival rates of offspring (P<0.0001). During this study, we formulated the principle that CLZ is not only able to block oocyte maturation and pregnancy but conversely can be utilized to produce oocytes with high developmental levels and fertilization rates. From the contraceptive point of view, CLZ merits further evaluation as a potential non-steroidal contraceptive. From the higher developmental and fertilization point of view, administration of CLZ in superovulation protocols merits continued investigation to address the potential inclusion of CLZ in infertility treatment.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ahmed M Taiyeb”